Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts (SCORPIO-PEP) @NEJMgroup
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts (SCORPIO-PEP) @NEJMgroup
Uploaded May 2026 | Updated September 2026, 2 weeks ago
Can ensitrelvir as postexposure prophylaxis prevent Covid-19 after household exposure?

Read the full SCORPIO-PEP trial results at NEJM.org.

#infectiousdisease #clinicaltrials #nejm
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts (SCORPIO-PEP)NEJM This Week — July 9, 2026Highly Pathogenic Avian Influenza A(H5N5) VirusHow Platform Trials Work | NEJM EvidenceVideos in Clinical Medicine: Placement of a Catheter for Acute Peritoneal Dialysis (Overview)When Race MattersStats, STAT!: Logistic Regression (Preview)Endovascular Therapy for Post-Thrombotic Syndrome (C-TRACT)NEJM This Week — May 14, 2026Clinical Practice: Polymyalgia RheumaticaNEJM This Week — July 30, 2026Clement Lee, M.D., Playing Doctordle — August 12, 2026
NEJM Group |

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts (SCORPIO-PEP)

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER